5-HT spinal antinociception involves mu opioid receptors: Cross tolerance and antagonist studies

British Journal of Anaesthesia

Volumn 78, Issue 5, 1997, Pages 563-569

  Goodchild, C S ^a,b   Guo, Z ^a   Freeman, J ^a   Gent, J P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Antagonists opioid; Pain, experimental; Pain, mechanisms; Pain, threshold; Serotonin (5 hydroxytryptamine)

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; 3,4 DICHLORO N [1 ISOPROPYL 2 (1 PYRROLIDINYL)ETHYL] N METHYLBENZENEACETAMIDE; BETA FUNALTREXAMINE; FENTANYL; FENTANYL CITRATE; MU OPIATE RECEPTOR; NALOXONE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; ELECTRIC CURRENT; INTRAPERITONEAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; RAT; SPINAL CORD; TAIL FLICK TEST;

EID: 0030927354     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/78.5.563     Document Type: Article

References (29)

1. Headley PM, Duggan AW, Griersmith BT. Selective reduction by noradrenaline and 5-hydroxytryptamine of nociceptive responses in cat dorsal horn neurones. Brain Research 1978; 145: 185-189.
2. Wang JK. Antinociceptive effect of intrathecally administered serotonin. Anesthesiology 1977; 47: 269-271.
3. Yaksh TL, Wilson PR. Spinal serotonin terminal systems mediate antinociception. Journal of Pharmacology and Experimental Therapeutics 1979; 208: 446-453.
4. Watkins LR, Cobelli DA, Faris P, Aceto MD, Mayer DJ. Opiate vs non-opiate footshock-induced analgesia (FSIA): the body region shocked is a critical factor. Brain Research 1982; 242: 299-308.
5. Rivot JP, Chaouch A, Besson JM. Nucleus raphe magnus modulation of response of rat dorsal horn neurons to unmyelinated fiber inputs: partial involvement of serotonergic pathways. Journal of Neurophysiology 1980; 44: 1039-1057.
6. 3 receptors modulate spinal nociceptive reflexes. Brain Research 1990; 510: 12-16.
7. Guo Z, Gent JP, Goodchild CS. Intrathecal 5-Hydroxytryptamine produces analgesia by activating spinal cord opioid pathways. Pain 1990; (Suppl 5): S103.
8. 3 receptors. Brain Research 1995; 704: 184-190.
9. Mjellem N, Lund A, Eide PK, Storkson R, Tjolsen A. The role of 5-HT1A and 5-HT1B receptors in spinal nociceptive transmission and in the modulation of NMDA induced behaviour. Neuroreport 1992; 3: 1061-1064.
10. Proudfit HK, Hammond DL. Alterations in nociceptive threshold and morphine-induced analgesia produced by intrathecally administered amine antagonists. Brain Research 1981; 218: 393-399.
11. Zemlan FP, Kow LM, Pfaff DW. Spinal serotonin (5-HT) receptor subtypes and nociception. Journal of Pharmacology and Experimental Therapeutics 1983; 226: 477-485.
12. Oliveras JL, Hosobuchi Y, Guilbaud G, Besson JM. Analgesic electrical stimulation of the feline nucleus raphe magnus: development of tolerance and its reversal by 5-HTP. Brain Research 1978; 146: 404-409.
13. Oliveras JL, Hosobuchi Y, Redjemi F, Guilbaud G, Besson JM. Opiate antagonist, naloxone, strongly reduces analgesia induced by stimulation of a raphe nucleus (centralis inferior). Brain Research 1977; 120: 221-229.
14. Akil H, Mayer DJ, Liebeskind JC. Reduction of stimulation-produced analgesia by the narcotic antagonist, naloxone. Science 1976; 191: 961-962.
15. Barbaro NM, Hammond DL, Fields HL. Effects of intrathecally administered methysergide and yohimbine on microstimulation-produced antinociception in the rat. Brain Research 1985; 343: 223-229.
16. Hammond DL, Yaksh TL. Antagonism of stimulation-produced antinociception by intrathecal administration of methysergide or phentolamine. Brain Research 1984; 298: 329-337.
17. Serrao JM, Stubbs SC, Goodchild CS, Gent JP. Intrathecal midazolam and fentanyl in the rat: evidence for different spinal antinociceptive effects. (Published erratum in Anesthesiology 1989; 71: 482.) Anesthesiology 1989; 70: 780-786.
18. Zimmerman M. Ethical guidelines for investigation of experimental pain on conscious animals. Pain 1983; 16: 109-110.
19. Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology 1990; 73: 273-277.
20. Goodchild CS, Serrao JM. Intrathecal midazolam in the rat: evidence for spinally-mediated analgesia. British Journal of Anaesthesia 1987; 59: 1563-1570.
21. Goodchild CS, Guo Z, Musgreave A, Gent JP. Antinociception by intrathecal midazolam involves endogenous neurotransmitters acting at spinal cord delta opioid receptors. British Journal of Anaesthesia 1996; 77: 758-763.
22. Goodchild CS, Sanghera S, Serrao JM, Gent JP. Analgesia mediated by spinal k-opioid receptors. European Journal of Anaesthesiology 1991; 8: 227-231.
23. Berzetei-Gurske IP, White A, Polgar W, Decosta BR, Pasternak GW, Toll L. The in vitro pharmacological characterization of naloxone benzoylhydrazone. European Journal of Pharmacology 1995; 277: 257-263.
24. Paul D, Bodnar RJ, Gistrak MA, Pasternak GW. Different μ receptor subtypes mediate spinal and supraspinal analgesia in mice. European Journal of Pharmacology 1989; 168: 307-314.
25. Saeki T, Nishimura M, Sato N, Fujinami T, Watanabe Y. Electrophysiological demonstration and activation of μ-opioid receptors in the rabbit sinoatrial node. Journal of Cardiovascular Pharmacology 1995; 26: 160-168.
26. Vanderschuren LJMJ, Niesink RJM, Spruijt BM, Van Ree JM. μ- and kappa-opioid receptor-mediated opioid effects on social play in juvenile rats. European Journal of Pharmacology 1995; 276: 257-266.
27. Arunlakshana O, Schild HO. Some quantitative uses of drug antagonists. British Journal of Pharmacology 1959; 14: 48-58.
28. Mackay D. Receptor classification using antagonists. Trends in Pharmacological Sciences 1991; 12: 181
29. Mackay D. A new method for estimating dissociation constants of competitive and non-competitive antagonists with no prior knowledge of agonist concentrations. British Journal of Pharmacology 1994; 111: 219-226.